The Hill: Merck Discontinuing
Development Of Two COVID-19 Vaccine Candidates
Merck has halted its development of two potential vaccines for the coronavirus,
citing data that showed a lack of immune response, Bloomberg reported. The two
vaccine candidates, which derive from technology used to develop Merck’s Ebola
and measles vaccines, generated fewer antibodies than existing vaccines,
according to interim trial data. (Budryk, 1/25)
No comments:
Post a Comment